Marc Chung is a Co-Founder of Granata Bio, where he leads strategic planning, partnerships, and business development to drive growth and long-term value. With extensive experience in healthcare consulting, analytics, and account strategy, including roles at IQVIA, Outcome Health, and Komodo Health, Marc bridges deep industry insight with commercial strategy to help bring innovative reproductive therapies to market. He holds a BA from Johns Hopkins University and an MBA from Yale School of Management. Learn more and connect with Marc on LinkedIn.
Marc Chung is a Co-Founder of Granata Bio, where he leads strategic planning, partnerships, and business development to drive growth and long-term value. With extensive experience in healthcare consulting, analytics, and account strategy, including roles at IQVIA, Outcome Health, and Komodo Health, Marc bridges deep industry insight with commercial strategy to help bring innovative reproductive therapies to market. He holds a BA from Johns Hopkins University and an MBA from Yale School of Management. Learn more and connect with Marc on LinkedIn.